Loading
ChemoMetec Stock: price and insider trades · Denmark
ChemoMetec: what insiders have been doing
ChemoMetec, classified in the Health Care sector, is a listed company based in Allerød Municipality, Denmark, founded in 1997. Its insiders report their share dealings to Finanstilsynet DK. The last twelve months, up to 18 October 2026, brought 4 filings signed by 4 insiders.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Insider buying of ChemoMetec has been absent for the past year. Half of the filings or more reach the Finanstilsynet DK feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades.
Across the 74 companies tracked on its exchange, the median is 4 filings; at 4 filings, this issuer sits right on that mark.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. This summary is built from Finanstilsynet DK disclosures alone and does not predict where the share price will go.
Key facts
Headquarters: Allerød Municipality, Denmark · Founded: 1997
Source: Wikidata (CC0).
Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 5,871 of 24,148 companies
64.5
score / 100
Value34
Quality96
FCF yld1.2%
Earn yld2.1%
EV/EBITDA32.8x
ROE29%
Gross mgn95%
Net mgn39%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
DKK 550.50
Analyst consensus
3 analystsDKK 550.00Target DKK 635.00(+15%)DKK 715.00
Income statement
RevenueDKK 511.1M
Gross profitDKK 486M95% margin
EBITDADKK 288.7M56% margin
Net incomeDKK 201.8M39.5% margin
Valuation
PER (trailing)47.5x
PER (forward)33.8x
P/Book13.1x
Beta1.39
Balance sheet & cash
Market capDKK 9.5B
Total debtDKK 4.6M
Free Cash FlowDKK 114M
Debt / Equity1%
Profitability & ownership
ROE28.6%
ROA18.5%
% insiders3.7%
% institutions54.0%
Last declaration on 27 March 2026
Declarations4 total
550 shares@ DKK 275.809.5% of flowShareDK:1429544
1,100 shares@ DKK 271.6018.8% of flowShareDK:1429530
3,355 shares@ DKK 280.9059.2% of flowShareDK:1429158
483 shares@ DKK 413.0012.5% of flowShareDK:1423563
4 of 4 declarations
About ChemoMetec
ChemoMetec is a company specializing in the development and manufacturing of measurement instruments for cell analysis. It offers innovative solutions for biomedical research and diagnostics.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
